Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice

被引:96
作者
Ghosh, AK
Hirasawa, N
Ohtsu, H
Watanabe, T
Ohuchi, K [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pathophysiol Biochem, Aoba Ku, Sendai, Miyagi 9808578, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Cellular Pharmacol, Sendai, Miyagi 9808575, Japan
关键词
cotton thread; dimaprit; histamine; macrophage; vascular endothelial growth factor;
D O I
10.1084/jem.20011782
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
We have analyzed the role of histamine in the angiogenesis of the granulation tissue in histidine decarboxylase-deficient (HDC-/-) mice, mast cell-deficient mice (WBB6F1-W/W-v), and their corresponding wild-type mice (HDC+/+ and VTBB6F(1)(+/+)). In HDC+/+ mice, subcutaneous implantation of a cotton thread in the dorsum induced granulation tissue formation with angiogenesis, while the topical injection of antivascular endothelial growth factor (VEGF) IgG strongly suppressed them. In HDC-/- mice which showed lower VEGF levels in the granulation tissue, there was notably less angiogenesis and granulation tissue formation than in HDC+/+ mice. The topical injection of histamine or the H-2 agonist dimaprit rescued the defective angiogenesis and granulation tissue formation in HDC-/- mice. There was no significant difference in the granulation tissue formation and angiogenesis between VTBB6F1-W/W-v and WBB6F1(+/+) mice. In addition, macrophages in the granulation tissue were found to express HDC. Our findings indicate that histamine derived from nonmast cells plays a significant role in the angiogenesis of the inflammatory granulation tissue.
引用
收藏
页码:973 / 982
页数:10
相关论文
共 40 条
[1]
THE INFLUENCE OF HISTAMINE ON IMMUNE AND INFLAMMATORY RESPONSES [J].
BEER, DJ ;
MATLOFF, SM ;
ROCKLIN, RE .
ADVANCES IN IMMUNOLOGY, 1984, 35 :209-268
[2]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]
BREIER G, 1992, DEVELOPMENT, V114, P521
[4]
COLVILLENASH PR, 1995, J PHARMACOL EXP THER, V274, P1463
[5]
ANGIOGENESIS AND RHEUMATOID-ARTHRITIS - PATHOGENIC AND THERAPEUTIC IMPLICATIONS [J].
COLVILLENASH, PR ;
SCOTT, DL .
ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (07) :919-925
[7]
FALUS A, 1992, IMMUNOL TODAY, V13, P154
[8]
ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[9]
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
[10]
Ghosh AK, 2000, J PHARMACOL EXP THER, V295, P802